Showing results (21-30 of 75) with videos related to
Sort By:
Pageof 8
The American Journal of Medicine|May 1, 1984
Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusionA Greenberg, B H Piraino, P D Kroboth, et al.Journal of Clinical Pharmacology|June 1, 1991
Alprazolam in end-stage renal disease: I. PharmacokineticsV D Schmith, B Piraino, R B Smith, et al.Clinical Pharmacology and Therapeutics|May 1, 1992
Alprazolam in end-stage renal disease. II. PharmacodynamicsV D Schmith, B Piraino, R B Smith, et al.Clinical Pharmacology and Therapeutics|November 1, 1985
Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interactionP D Kroboth, R B Smith, G P Stoehr, et al.Journal of Chromatography|July 17, 1991
New high-performance liquid chromatographic method for the determination of alprazolam and its metabolites in serum: instability of 4-hydroxyalprazolamV D Schmith, S R Cox, M A Zemaitis, et al.Pharmacology, Biochemistry, and Behavior|May 1, 1993
Modulation of [3H]flunitrazepam binding by natural and synthetic progestational agentsJ W McAuley, P D Kroboth, D D Stiff, et al.Biopharmaceutics & Drug Disposition|November 1, 1986
Mechanism for the interaction between triazolam and cimetidineS R Cox, P D Kroboth, P H Anderson, et al.Journal of Clinical Psychopharmacology|October 1, 1995
Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolamR H Barbhaiya, U A Shukla, P D Kroboth, et al.Archives of Internal Medicine|June 1, 1983
Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysisP D Kroboth, M A McNeil, A Kreeger, et al.Journal of Clinical Pharmacology|August 1, 1987
Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effectsP D Kroboth, R B Smith, D H Van Thiel, et al.Pageof 8